BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3302052)

  • 1. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.
    Täuber MG; Shibl AM; Hackbarth CJ; Larrick JW; Sande MA
    J Infect Dis; 1987 Sep; 156(3):456-62. PubMed ID: 3302052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
    Friedland IR; Jafari H; Ehrett S; Rinderknecht S; Paris M; Coulthard M; Saxen H; Olsen K; McCracken GH
    J Infect Dis; 1993 Sep; 168(3):657-62. PubMed ID: 8354907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pefloxacin in experimental Escherichia coli meningitis.
    Shibl AM; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1986 Mar; 29(3):409-11. PubMed ID: 3521484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid administration, brain edema, and cerebrospinal fluid lactate and glucose concentrations in experimental Escherichia coli meningitis.
    Täuber MG; Sande E; Fournier MA; Tureen JH; Sande MA
    J Infect Dis; 1993 Aug; 168(2):473-6. PubMed ID: 8335989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy of fulminant E. coli K1 sepsis in infant rabbits.
    Law BJ; Rettig PJ; Marks MI
    Pediatr Res; 1984 Apr; 18(4):314-7. PubMed ID: 6371694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of cefotaxime in gram-negative meningitis.
    LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW
    Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime therapy of neonatal gram-negative bacillary meningitis.
    Naqvi SH; Maxwell MA; Dunkle LM
    Pediatr Infect Dis; 1985; 4(5):499-502. PubMed ID: 3900946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis.
    Shenep JL; Barton RP; Mogan KA
    J Infect Dis; 1985 Jun; 151(6):1012-8. PubMed ID: 3889171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.
    Beam TR; Allen JC
    Antimicrob Agents Chemother; 1980 Jan; 17(1):37-42. PubMed ID: 6986115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of gram-negative bacillary meningitis: role of the new cephalosporin antibiotics.
    Cherubin CE; Corrado ML; Nair SR; Gombert ME; Landesman S; Humbert G
    Rev Infect Dis; 1982; 4 Suppl():S453-64. PubMed ID: 6294799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):433-6. PubMed ID: 3907493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of purulent meningitis with ceftriaxone].
    Guggenbichler JP; Parth J
    Wien Med Wochenschr Suppl; 1985; 87():12-6. PubMed ID: 3856970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of anisodamine and ampicillin on cerebrospinal fluid in experimental E coli meningitis].
    Liu YX
    Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):289-91, 320. PubMed ID: 8221249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime pharmacokinetics and treatment of meningitis in neonates.
    Jacobs RF; Kearns GL
    Infection; 1989; 17(5):338-42. PubMed ID: 2689352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y; Boccazzi A; McCracken GH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms.
    Kaplan SL; Patrick CC
    Pediatr Infect Dis J; 1990 Nov; 9(11):810-4. PubMed ID: 2263430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four aminoglycoside antibiotics in the therapy of experimental E. coli meningitis.
    Strausbaugh LJ; Mandaleris CD; Sande MA
    J Lab Clin Med; 1977 Apr; 89(4):692-701. PubMed ID: 321713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.